login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
IO BIOTECH INC (IOBT) Stock News
USA
-
Nasdaq
- NASDAQ:IOBT -
US4497781090
-
Common Stock
0.6967
USD
+0.02 (+2.74%)
Last: 12/5/2025, 8:00:02 PM
0.7138
USD
+0.02 (+2.45%)
After Hours:
12/5/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IOBT Latest News, Press Relases and Analysis
All
Press Releases
18 days ago - By: Chartmill
- Mentions:
VNDA
CMCT
ARVN
ZYXI
...
Top movers in Tuesday's session
10 days ago - By: IO Biotech
IO Biotech Announces Participation in Upcoming December Investor Conferences
17 days ago - By: BioMedWire
- Mentions:
OTLC
NVS
BCAX
PFE
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
17 days ago - By: Zacks Investment Research
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why
18 days ago - By: Benzinga
- Mentions:
ZYXI
ITRM
ARVN
OLMA
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
23 days ago - By: IO Biotech
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
25 days ago - By: IO Biotech
IO Biotech Announces Participation in Upcoming Investor Conferences
a month ago - By: IO Biotech
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
a month ago - By: Benzinga
- Mentions:
MOH
BIOA
ITGR
ARMP
...
12 Health Care Stocks Moving In Thursday's Intraday Session
2 months ago - By: IO Biotech
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
2 months ago - By: Stocktwits
- Mentions:
MRK
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine
2 months ago - By: IO Biotech
IO Biotech Provides Update Following Pre-BLA Meeting with FDA
2 months ago - By: IO Biotech
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
3 months ago - By: IO Biotech
IO Biotech Announces Participation in Upcoming Investor Conferences
3 months ago - By: Zacks Investment Research
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's What You Should Know
3 months ago - By: Yahoo Finance
H.C. Wainwright Reiterates Buy Rating on IO Biotech, Keeps PT at $14
4 months ago - By: The Motley Fool
Io Biotech Posts Wider Loss in Q2
Please enable JavaScript to continue using this application.